BRIEF published on 09/25/2024 at 15:05, 4 days 10 hours ago GEN Reports Positive Phase 2 Trial Results for GN-037 Topical Cream Clinical Efficacy Phase 2 Trial Results GN-037 Topical Cream Plaque Psoriasis Treatment GEN Pharmaceuticals
PRESS RELEASE published on 09/25/2024 at 15:00, 4 days 10 hours ago GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis GEN Pharmaceuticals announces positive Phase 2 trial results for GN-037 topical cream in treating plaque psoriasis, presented at EADV Congress 2024 Phase 2 Trial GN-037 Topical Cream GEN Pharmaceuticals Plaque Psoriasis EADV Congress
Published on 09/28/2024 at 02:06, 1 day 23 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 23 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 2 days 1 hour ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/29/2024 at 19:15, 6 hours 6 minutes ago EQS-Adhoc: BayWa AG: Extension of the standstill agreements and increase in bridge financing
Published on 09/28/2024 at 14:01, 1 day 11 hours ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 2 days 2 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 2 days 3 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 2 days 6 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 17:45, 2 days 7 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 3 days 7 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 3 days 7 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 3 days 7 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024